AI: Does Europe Have the Answer?
KFF ·
When health systems are stressed, Martin McKee has been there taking notes. He's spent four decades studying collapse and recovery — the post-Soviet transition, the 2008 financial crisis, the COVID-19 pandemic. Now, as professor of European public health at the London School of Hygiene and Tropical Medicine and research director of the European Observatory on Health Systems and Policies, he's turned that lens on AI. He arrives at a charged moment: America is locked in a debate over whether AI development should slow down or even pause. Europe made a different choice — binding AI with some of the world's strictest rules. After a run of episodes examining AI through a U.S. lens, Chip and McKee cross the Atlantic: What does the American debate look like from Europe — and does regulation offer an answer that a pause cannot?
When health systems are stressed, Martin McKee has been there taking notes. He's spent four decades studying collapse and recovery — the post-Soviet transition, the 2008 financial crisis, the COVID-19 pandemic. Now, as professor of European public health at the London School of Hygiene and Tropical Medicine and research director of the European Observatory on Health Systems and Policies, he's turned that lens on AI. He arrives at a charged moment: America is locked in a debate over whether AI development should slow down or even pause. Europe made a different choice — binding AI with some of the world's strictest rules. After a run of episodes examining AI through a U.S. lens, Chip and McKee cross the Atlantic: What does the American debate look like from Europe — and does regulation offer an answer that a pause cannot?